Literature DB >> 12041670

CDNA microarray analysis of chronic myeloid leukemia.

Huiyu Li1, Shenghua Jie, Ping Zou, Guolin Zou.   

Abstract

A series of expression microarray analyses of chronic myeloid leukemia (CML) by means of complementary DNA microarray representing a set of 1024 human genes were initiated to evaluate the role of expression microarray analysis in CML and to identify CML-associated genes. Among the target genes, 388 differentially expressed genes were identified. In 2 cases the expression level of 74 to 91 genes and in 3 cases that of 45 genes differed between the normal control and CML cells. Results of analysis of messenger RNA profiles indicated that 19 of 45 differentially expressed genes were up-regulated whereas others were down-regulated. The expression profile included oncogenes, tumor suppression genes, and human genes encoding proteins involved in the functions of transcription, signal transduction, metabolism, cell growth, differentiation, and apoptosis. The function of the immune system also was observed. Identification of these genes allows a quantitative view of the changes that accompany CML at the genomic level and enables deeper insights into the molecular basis of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12041670     DOI: 10.1007/bf02982130

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  cDNA isolation, expression analysis, and chromosomal localization of two human zinc finger genes.

Authors:  L Lania; E Donti; A Pannuti; A Pascucci; G Pengue; I Feliciello; G La Mantia; L Lanfrancone; P G Pelicci
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

2.  Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines.

Authors:  B Druker; K Okuda; U Matulonis; R Salgia; T Roberts; J D Griffin
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

3.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.

Authors:  D Shalon; S J Smith; P O Brown
Journal:  Genome Res       Date:  1996-07       Impact factor: 9.043

4.  Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.

Authors:  M Schena; D Shalon; R Heller; A Chai; P O Brown; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  Anaemia and antioxidant defence of the red blood cells.

Authors:  A Kumerova; A Lece; A Skesters; A Silova; V Petuhovs
Journal:  Mater Med Pol       Date:  1998 Jan-Jun

6.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

7.  Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

Authors:  U Kordes; D Krappmann; V Heissmeyer; W D Ludwig; C Scheidereit
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

8.  A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.

Authors:  J Y Reuther; G W Reuther; D Cortez; A M Pendergast; A S Baldwin
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

9.  BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.

Authors:  A M Pendergast; L A Quilliam; L D Cripe; C H Bassing; Z Dai; N Li; A Batzer; K M Rabun; C J Der; J Schlessinger
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

Review 10.  A tiger behind many doors: multiple genetic pathways to malignant glioma.

Authors:  D N Louis; J F Gusella
Journal:  Trends Genet       Date:  1995-10       Impact factor: 11.639

View more
  2 in total

1.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

2.  Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.

Authors:  Xiaofeng Dai; Xiao Chen; Olivier Hakizimana; Yi Mei
Journal:  Oncol Rep       Date:  2019-09-24       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.